Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Wallet

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Clinical Medicine & Research|September 15, 2005
Immunoregulation of dendritic cellsMark A Wallet, Pradip Sen, Roland Tisch
Frontiers in Immunology|March 15, 2021
Influence of <i>PTPN22</i> Allotypes on Innate and Adaptive Immune Function in Health and DiseaseLucas H Armitage, Mark A Wallet, Clayton E Mathews
Frontiers in Endocrinology|November 3, 2017
Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1 DiabetesMark A Wallet, Katherine E Santostefano, Naohiro Terada, et al.
Journal of Leukocyte Biology|December 17, 2009
Proteome bioprofiles distinguish between M1 priming and activation states in human macrophagesJoseph Brown, Mark A Wallet, Bryan Krastins, et al.
Cellular Immunology|March 20, 2010
IFNgamma primes macrophages for inflammatory activation by high molecular weight hyaluronanMark A Wallet, Shannon M Wallet, Giorgio Guiulfo, et al.
Journal of Immunology and Regenerative Medicine|December 3, 2019
Dendritic Cells Treated with Exogenous Indoleamine 2,3-Dioxygenase Maintain an Immature Phenotype and Suppress Antigen-specific T cell ProliferationEvelyn Bracho-Sanchez, Azadeh Hassanzadeh, Maigan A Brusko, et al.
Biology Open|November 25, 2020
Harmine enhances the activity of the HIV-1 latency-reversing agents ingenol A and SAHAJared P Taylor, Lucas H Armitage, Daniel L Aldridge, et al.
Journal of Leukocyte Biology|February 14, 2018
CRISPR/Cas9 knockout of USP18 enhances type I IFN responsiveness and restricts HIV-1 infection in macrophagesJared P Taylor, Melanie N Cash, Katherine E Santostefano, et al.
Diabetes|February 24, 2007
The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic miceShannon M Pop, Carmen P Wong, Qiuming He, et al.
AIDS Research and Human Retroviruses|February 2, 2017
HIV-1 Infection Primes Macrophages Through STAT Signaling to Promote Enhanced Inflammation and Viral ReplicationK Sofia Appelberg, Mark A Wallet, Jared P Taylor, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Clinical Medicine & Research|September 15, 2005
Immunoregulation of dendritic cellsMark A Wallet, Pradip Sen, Roland Tisch
Frontiers in Immunology|March 15, 2021
Influence of <i>PTPN22</i> Allotypes on Innate and Adaptive Immune Function in Health and DiseaseLucas H Armitage, Mark A Wallet, Clayton E Mathews
Frontiers in Endocrinology|November 3, 2017
Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1 DiabetesMark A Wallet, Katherine E Santostefano, Naohiro Terada, et al.
Journal of Leukocyte Biology|December 17, 2009
Proteome bioprofiles distinguish between M1 priming and activation states in human macrophagesJoseph Brown, Mark A Wallet, Bryan Krastins, et al.
Cellular Immunology|March 20, 2010
IFNgamma primes macrophages for inflammatory activation by high molecular weight hyaluronanMark A Wallet, Shannon M Wallet, Giorgio Guiulfo, et al.
Journal of Immunology and Regenerative Medicine|December 3, 2019
Dendritic Cells Treated with Exogenous Indoleamine 2,3-Dioxygenase Maintain an Immature Phenotype and Suppress Antigen-specific T cell ProliferationEvelyn Bracho-Sanchez, Azadeh Hassanzadeh, Maigan A Brusko, et al.
Biology Open|November 25, 2020
Harmine enhances the activity of the HIV-1 latency-reversing agents ingenol A and SAHAJared P Taylor, Lucas H Armitage, Daniel L Aldridge, et al.
Journal of Leukocyte Biology|February 14, 2018
CRISPR/Cas9 knockout of USP18 enhances type I IFN responsiveness and restricts HIV-1 infection in macrophagesJared P Taylor, Melanie N Cash, Katherine E Santostefano, et al.
Diabetes|February 24, 2007
The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic miceShannon M Pop, Carmen P Wong, Qiuming He, et al.
AIDS Research and Human Retroviruses|February 2, 2017
HIV-1 Infection Primes Macrophages Through STAT Signaling to Promote Enhanced Inflammation and Viral ReplicationK Sofia Appelberg, Mark A Wallet, Jared P Taylor, et al.
Pageof 3